Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy ; volume:7 ; number:1 ; day:10 ; month:12 ; year:2012 ; pages:1-6 ; date:12.2012
Radiation oncology ; 7, Heft 1 (10.12.2012), 1-6, 12.2012
- Creator
- Contributor
-
Piroth, Marc D.
Holy, Richard
Djukic, Victoria
Klotz, Jens
Pfister, David
Heidenreich, Axel
Eble, Michael J.
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-7-209
- URN
-
urn:nbn:de:1111-2016072616731
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinkawa, Michael
- Piroth, Marc D.
- Holy, Richard
- Djukic, Victoria
- Klotz, Jens
- Pfister, David
- Heidenreich, Axel
- Eble, Michael J.
- SpringerLink (Online service)
Other Objects (12)
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Biomarkers for prostate cancer: prostate-specific antigen and beyond
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Biomarkers for prostate cancer: prostate-specific antigen and beyond
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Biomarkers for prostate cancer: prostate-specific antigen and beyond
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: a scoping review and meta-analysis
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma